We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
Focussed analysis of 53 Chinese clinical trials shows efficacy of probiotic formula Medilac-S as adjuvant treatment in ulcerative colitis and prevention of anti-inflammatory side effects